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Iminobiotin is a cyclic guanidino analogue of biotin and combines with avidin. Although the affinity of iminobiotin with avidin (10 8 M -1 at pH 9.5) is weaker than that of biotin, 10 it is useful in monitoring a biomolecule interaction. Therefore, the selective retrieval of iminobiotin-derivatized plasma membrane proteins was established with affinity columns. 11 In addition, biotin assay using avidin-peroxidase conjugate and iminobiotin immobilized on the polystyrene beads has been reported. 12 The reversible attribute of avidin-iminobiotin binding makes possible repeated usage of a column or beads.
In this study, an interaction between avidin and iminobiotin labeled with an electroactive substance was investigated. We have reported a method to monitor avidin-biotin interaction using biotin labeled with an electroactive compound. 13 The avidin-biotin interaction can be evaluated by the decrease of peak current of labeled biotin (LB), because the electroactive moiety is covered with the binding site of avidin. This also might be related to the decrease of diffusion constant of LB. Free biotin was detected using the competitive reaction to avidin between LB and free biotin. If a labeled iminobiotin (LI) is used instead of LB, free biotin may be able to replace the LI which already has formed a complex with avidin ( Fig. 1 ). That is, the peak current of LI increases by addition of the free biotin in solution including the avidin-LI complex. Daunomycin was selected as an electroactive label. Because the label adsorbs on a carbon electrode, the LI can be detected with accumulation voltammetry sensitively. In addition, daunomycin is one of the anticancer drugs and is not present in natural products. Therefore, the possibility of contamination from the sample matrix is very low. On the other hand, daunomycin, which has an amino group in a part of the sugar, can be iminobiotinylated with a commercially available iminobiotinylating reagent.
Since the electroactive and iminobiotin moieties are far apart, it is anticipated that these functions will not interfere with each other. Thus, a new voltammetric homogeneous binding assay for biotin is achieved by using LI-avidin complex.
Experimental
Reagents NHS-iminobiotin trifluoroacetamide as a biotinyl reagent was supplied from Pierce (Rockford, IL). Avidin and daunomycin were purchased from Wako Pure Industries, Japan. Phosphate buffer (pH 7.0) of 0.1 M with KH2PO4 of 0.1 M and NaOH of 0.1 M was used as an incubation solution and as a supporting electrolyte in voltammetric measurements.
High quality nitrogen gas was used for deaeration. All reagents were of analytical reagent grade.
Apparatus
A CV-50 W voltammetric analyzer (Bioanalytical Systems Inc. (BAS)) was used for all measurements. The working electrode was a glassy carbon electrode (Model No. 11-2012, BAS). Before each measurement, the electrode was polished with 1.0, 0.3 and 0.05 µm alumina (Baikoski International Co., Charlotte, NC), in order. The counter electrode was a platinum wire, and an Ag/AgCl electrode (Model No. 11-2210, BAS) was used as a reference electrode. All potentials were measured against the Ag/AgCl electrode. The pH of buffer solution was recorded with a Horiba D-21 pH meter. Measurements of visible spectra of daunomycin and the labeled iminobiotin were carried out with a UV 1240 mini spectrophotometer (Shimadzu Tokyo, Japan).
Preparation of labeled iminobiotin (LI)
Labeled iminobiotin (LI) was prepared by reaction between daunomycin and biotinyl reagent for 24 h at 4˚C in 0.1 M phosphate buffer solution (pH 8.0) (Fig. 2) . The solution was spotted on a sheet used for thin-layer chromatography (silica gel alumina sheet, Merck) in chloroform:methyl alcohol:formic acid = 40:10:1 (v/v) %. After developing, the LI was stripped from the sheet and collected. The reagent was dissolved in ethylalcohol, and the solution was centrifuged to exclude silica gel. The concentration of LI was determined on the basis of the mole absorbance efficiency of daunomycin at 490 nm. 13 
Procedure of voltammetric measurement
After avidin and LI were incubated for 1 h in 10 ml of 0.1 M phosphate buffer (pH 7.0), a potential at -1.0 V was applied to the electrode for 5 min with stirring. After a rest period of 15 s, an oxidation response of LI was measured by scanning the potential between -1.0 and 0.0 V with a differential pulse voltammetry (scan rate: 5 mV s -1 , pulse amplitude: 50 mV, sample width: 2 ms, pulse width: 50 ms, pulse period: 200 ms). For detection of free biotin, the replacement reaction of LI by biotin was used. Free biotin was added to the solution containing avidin-LI complex. The solution was mixed for 1 h. If enough of the solution containing the complex is prepared and it can be divided among several cells, the voltammetric measuring time is shortened to less than 2 h. Voltammograms are recorded under the same conditions as described above. Figure 3 shows voltammograms of 5 × 10 -7 M LI (curve a) and the avidin-LI complex (curve b). An oxidation peak due to daunomycin moiety appeared at about -0.60 V in 0.1 M phosphate buffer (pH 7.0) with 5 × 10 -7 M LI. The peak current of LI depended on the accumulation time and was linear until 7 min. For the concentration of LI, the peak current was in proportion between 5 × 10 -9 M and 7 × 10 -7 M. On the other hand, the peak potential of LI shifted to the more negative side with increasing pH because protons are related to the electrode reaction.
Results and Discussion

Voltammograms of the avidin-LI complex and with biotin added
The electrode response of avidin-LI complex was measured after 5 × 10 -7 M LI and 2 × 10 -6 M avidin were mixed for 1 h in the solution. The peak current of LI decreased to about 5% in comparison with the case in which avidin did not exist. The reason was that daunomycin moiety was covered with such a large volume of avidin that it lost electroactivity. On the other hand, the peak current obtained by addition of 1 × 10 -6 M biotin 898 ANALYTICAL SCIENCES AUGUST 2005, VOL. 21 to solution containing the avidin-LI complex (curve c) was recovered and became half for the peak current of LI (curve a). In previous study, such a phenomenon was not observed in the case of avidin-labeled biotin (LB) complex. 13 This is caused by the very high binding constant of avidin-LB complex, compared with that of the avidin-LI complex.
Effect of pH on the interaction between avidin and LI
The effect of pH was investigated in 0.1 M KH2PO4-NaOH containing 5 × 10 -7 M LI (Fig. 4) . A current value from daunomycin moiety in LI is changeable by adjusting the pH of the solution because the peak is based on the oxidation from the hydroxyl group to the quinone. The peak current of LI at pH 5.6 was a maximum value. Furthermore, the binding of iminobiotin to avidin depends on the pH due to the structure of iminobiotin. When the pH was 4.6, the peak current of LI hardly changed in the incubation with avidin. That is, the avidin-LI binding does not occur at pH 4.6. The avidin-LI interaction was observed for pH values ranging between 5.6 and 8.9. The measurement over pH 8.9 was not carried out with this method because the detection of LI itself is out of the sensitivity range. The largest change in the peak current of LI by incubation with avidin was observed at pH 7.0, which is within pH range of this experiment. For incubation time with avidin, the peak currents of LI decreased up to 40 min drastically and the current became constant over 50 min. Therefore, the incubation time was decided to be 60 min.
The binding constant to avdin of iminobiotin is smaller than that of biotin. In addition, the binding constant between avidin and LI decreases due to the labeling. Therefore, the avidin/biotin ratio is not 4:1, and an excess concentration of avidin is needed. On the other hand, these results suggest that iminobiotin-modified electrode can immobilize avidin with a functional molecule. Furthermore, the avidin dissociates from the electrode surface when the pH value in a solution is less than 4.6. From the feature, the electrode has a possibility of reutilization.
Replacement of LI by biotin in the avidin-LI complex
To examine whether the avidin-LI complex became an avidinbiotin complex, the replacement time was investigated. Biotin was added to the solution that included the avidin-LI complex. As a result, the peak current of LI increased with increasing the 899 ANALYTICAL SCIENCES AUGUST 2005, VOL. 21 Fig. 4 Dependence of pH to the interaction between avidin and LI. c, pH 4.6; g, pH 5.6; d, pH 6.0; a, pH 7.0; f, pH 8.0; s, pH 8.9. LI of 5 × 10 -7 M was added to 0.1 M KH2PO4-NaOH with avidin, and the solution was mixed for 1 h. Measurements were carried out with DPV, after a potential at -1.0 V for 5 min was applied to the electrode. replacement time (Fig. 5) . Thus, the replacement of iminobiotin to biotin observed by means of chromatography 10 and spectrometry 14 was confirmed as well by voltammetric procedure.
This method achieves the voltammetric detection of biotin based on non-competitive homogeneous binding assay without separating the bound and free biotin. After the avidin-LI complex was formed in 0.1 M phosphate buffer (pH 7.0), a suitable concentration of biotin was added to the solution. In the presence of 5 × 10 -7 M LI and 2 × 10 -6 M avidin, the measurements were carried out in the range of 10 -9 -10 -4 M biotin (Fig. 6 ). The peak current of LI increased with increasing the concentration of biotin, and the responses showed a dose curve. The relative standard deviation at 1 × 10 -7 M biotin was about 5.2% (n = 5). The detection limit of biotin was 5 × 10 -9 M estimated from three times the standard deviation (3σ).
In this study, iminobiotin labeled with daunomycin was prepared, and it combined with avidin in a solution. When avidin-iminobiotin complex and biotin were incubated, the peak current of LI increased because the avidin-LI complex becomes avidin-biotin complex. The merit of the proposed method was that a separation of the bound and free biotin was unnecessary. Because the formation of avidin-LI complex is influenced by the pH of solution, the concept is applied to immobilize avidin with functional substances such as antigen and antibody. We will investigate iminobiotin-modified electrodes.
